Loading...
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is well known as an aggressive disease with poor survival. This has sparked trials of alternate immune-based therapies in MPM. While up to a quarter of MPM patients respond to immune checkpoint inhibitors (ICIs), predicting response remains challengin...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354134/ https://ncbi.nlm.nih.gov/pubmed/32676326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-485 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|